SCHEMBL8256202

SCHEMBL8256202

CC(C)C1CC1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6757980 1.00
SCHEMBL6883369 1.00
SCHEMBL6757966 1.00
SCHEMBL6758020 1.00
SCHEMBL6884434 1.00
SCHEMBL6758012 1.00
Bicarbonate SCHEMBL11291705 0.88 TRPA1 (0.44)
SCHEMBL11376568 0.84
SCHEMBL5868611 0.84
(-)-(1S,3R,4S,6S)-6-Hydroxymenthol SCHEMBL7043768 0.84 TRPA1 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12391802-B2 Method of forming semicrystalline polyetherimide, and polyetherimide-containing composition SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2025-08-19 US disclosed
US-20230374035-A1 RAS INHIBITORS Revolution Medicines, Inc. 2023-11-23 US disclosed
US-20230233569-A1 METHODS FOR DELAYING, PREVENTING, AND TREATING ACQUIRED RESISTANCE TO RAS INHIBITORS WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT 2023-07-27 US disclosed
US-20230226186-A1 RAS INHIBITORS WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT 2023-07-20 US disclosed
US-11690915-B2 Ras inhibitors Revolution Medicines, Inc. (US) 2023-07-04 US disclosed
US-20220162387-A1 METHOD OF FORMING SEMICRYSTALLINE POLYETHERIMIDE, AND POLYETHERIMIDECONTAINING COMPOSITION SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2022-05-26 US disclosed
CN-113748155-A Methods of forming semi-crystalline polyetherimides and compositions comprising polyetherimides 高新特殊工程塑料全球技术有限公司 2021-12-03 CN disclosed
WO-2020234683-A1 METHOD OF FORMING SEMICRYSTALLINE POLYETHERIMIDE, AND POLYETHERIMIDE-CONTAINING COMPOSITION SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2020-11-26 WO disclosed
EP-3741792-A1 METHOD OF FORMING SEMICRYSTALLINE POLYETHERIMIDE, AND POLYETHERIMIDE-CONTAINING COMPOSITION SABIC Global Technologies B.V. (NL) 2020-11-25 EP disclosed
WO-2020193649-A1 NEW THERAPEUTIC APPLICATION OF 1,2-DIOXOLANE-3,5-DISUBSTITUTED COMPOUNDS, AND METHOD FOR THE PRODUCTION THEREOF Universite Paris-Saclay (FR) 2020-10-01 WO disclosed
WO-2020193650-A1 PROCESS FOR PREPARING 1,2-ENDOPEROXIDE COMPOUNDS Universite Paris-Saclay (FR) 2020-10-01 WO disclosed
US-7312334-B2 Method of preparing inhibitors phosphodiesterase-4 MERCK & CO. INC. (US) 2007-12-25 US disclosed
US-20040102472-A1 Method of preparing inhibitors of phosphodiesterase-4 MERCK & CO., INC. 2004-05-27 US disclosed